Hinge Health, Inc. <HNGE.N>: Stifel Raises Target Price to $96 From $90
HNGE•Related News
Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
LXEO•
Rambus Initiates $100 Million Accelerated Share Repurchase Program
RMBS•
Kymera Therapeutics posts corporate deck outlining push to develop oral targeted protein degraders for immunology
KYMR•
Lufax reports 1,733,377,784 total issued shares as of July 31, 2026
LU•
Digital Brands Group receives all-cash buyout proposal at USD 77.58 per share
DBGI•